1. ACTOVEGIN® IN THERAPY OF SUBCLINICAL DISTAL SYMMETRICAL SENSOR-MOTOR POLYNEUROPATHY IN 2ND TYPE DIABETES MELLITUS
- Author
-
A. S. FOKINA, I. A. STROKOV, and А. V. ZILOV
- Subjects
2nd type diabetes mellitus ,diabetic polyneuropathy distribution ,punch-biopsy ,computer capillaroscopy ,effectiveness of actovegin® treatment ,Medicine - Abstract
A study of 103 2nd diabetes mellitus inpatients was carried out with the help of the composite test (clinical scales TSS and NIS LL + 7 EMG-characteristics of the leg peripheral nerves’ state) for diagnosing and establishing stages of diabetic polyneuropathy. In 75% of patients distal symmetric sensor-motor diabetic polyneuropathy is detected, from them – in 33% subclinical stage. In 30 patients with subclinical stage of the diabetic polyneuropathy treatment by Actovegin® was conducted for 5 months: 10 infusions 250.00 ml of 20%-solution and then administration of Actovegin® tablets at a dosage 200 mg 3 tpd. At examination after the course of treatment improvement of the capillary blood flow, increase of density of thin fibers in epidermis and skin (punch-biopsy), content of endothelium in the skin, activation of neoanginesis. Discussing the literature data and own findings a conclusion about effectiveness of Actovegin® in the 2nd diabetes mellitus patients with polyneuropathy, including at a subclinical stage.
- Published
- 2016
- Full Text
- View/download PDF